Association between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population

Simple item page
dc.contributor.authorHashemi, Mohammad
dc.contributor.authorAmininia, Shadi
dc.contributor.authorEbrahimi, Mahboubeh
dc.contributor.authorHashemi, Seyed M
dc.contributor.authorTaheri, Mohsen
dc.contributor.authorGhavami, Saeid
dc.date.accessioned2014-12-17T22:26:06Z
dc.date.available2014-12-17T22:26:06Z
dc.date.issued2014-12-10
dc.date.updated2014-12-16T16:14:24Z
dc.description.abstractAbstract Background Breast cancer (BC) is considered to be one of the most important causes of death worldwide, and it affects the Iranian female population a decade earlier than female in other parts of the world. Human telomerase reverse transcriptase (hTERT) is a main subunit of the telomerase complex. MNS16A is located downstream of the hTERT gene and is recognized as the regulator of hTERT promoter activity. The aim of the present study was to access the possible impact of hTERT variants on BC risk in an Iranian population in southeast Iran. Methods A total of 491 subjects including 266 BC patients and 225 healthy women participated in the study. Polymerase chain reaction (PCR) was used to genotype the MNS16A variable number of tandem repeats and 177 bp ins/del polymorphisms in the hTERT gene. PCR-RFLP and ARMS-PCR were used to genotype hTERT rs2736098 and 2735940, respectively. The association between genotypes and BC was assessed by computing the odds ratio (OR) and 95% confidence intervals (95% CI) from logistic regression analyses. A p-value of <0.05 was considered statistically significant. Results The MNS16A genotype frequency distribution in BC patients was: LL, 43.2%; LS, 51.1%; and SS, 5.7%, and in controls: LL, 29.5%; LS, 68.3%; and SS, 2.2%. The LS genotype decreased the risk of BC compared with LL (OR = 0.51, 95% CI = 0.35-0.75, p < 0.001). The hTERT 177 bp ins/del polymorphism was not polymorphic in our population. All subjects had the ins/ins genotype. Our findings indicate that the MNS16A genotype and hTERT rs2736098 variant were associated with BC risk in the study. We also showed that the rs2736098 A/G polymorphism increased the risk of BC (OR = 1.80, 95% CI = 1.12-2.88, p = 0.017, AG vs AA; OR = 1.80, 95% CI = 1.06-3.06, p = 0.033, GG vs AA; OR = 1.87, 95% CI = 1.19-2.94, p = 0.006, AG + GG vs AA). No significant association was found between the rs2735940 C/T variant and BC. Conclusion Our findings indicate that the MNS16A genotype and the hTERT rs2736098 variant influence the risk of BC in an Iranian population in southeast Iran.
dc.description.versionPeer Reviewed
dc.identifier.citationBMC Research Notes. 2014 Dec 10;7(1):895
dc.identifier.doihttp://dx.doi.org/10.1186/1756-0500-7-895
dc.identifier.urihttp://hdl.handle.net/1993/30121
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderMohammad Hashemi et al.; licensee BioMed Central Ltd.
dc.titleAssociation between hTERT polymorphisms and the risk of breast cancer in a sample of Southeast Iranian population
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
1756-0500-7-895.xml
Size:
104.79 KB
Format:
Extensible Markup Language
Description:
Download
Thumbnail Image
Name:
1756-0500-7-895.pdf
Size:
408.2 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.17 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works